Rapport Therapeutics, Inc. · NASDAQ:RAPP
Rapport Therapeutics, Inc. shareholders
As of Jun 30, 2026, 150 institutions reported holding Rapport Therapeutics, Inc. Largest: Fidelity, Trv Gp V, LLC and ARCH Venture Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Rapport Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Fidelity | 7.17M | +3,955 | Aug 13, 2026 | |
| Trv Gp V, LLC | 6.28M | −855K | Aug 10, 2026 | |
| ARCH Venture Management, LLC | 3.73M | no change | Aug 14, 2026 | |
| Capital Group | 3.47M | −161K | Aug 12, 2026 | |
| Goldman Sachs | 2.91M | −31,802 | Aug 14, 2026 | |
| BlackRock | 2.7M | +194K | Aug 7, 2026 | |
| Cormorant Asset Management, LP | 2.66M | −300K | Aug 14, 2026 | |
| Vanguard | 1.96M | +79,545 | Aug 13, 2026 | |
| Sofinnova Investments, Inc. | 1.9M | no change | Aug 14, 2026 | |
| Johnson & Johnson | 1.78M | no change | Aug 6, 2026 |